University of Texas, Austin   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Austin TX United States (1883)

Organization Overview

First Clinical Trial
1996
NCT06046924
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Dell Medical School at The University of Texas at Austin | Department of Psychology, University of Texas at Austin | Emily Dunlap | Texas Cardiac Arrhythmia Institute, Austin, TX, USA | The University of Texas at Austin | The University of Texas at Austin Dell Medical School | University of Texas at Austin | University of Texas at Austin/ Dell Medical School | University of Texas, Austin | UT Austin | UT Dell Medical School

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Drinking (Phase 1)

Alcoholism (Phase 1)

Bipolar Disorder (Phase 1)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Disease (Phase 1)

Foot-and-Mouth Disease (Phase 2)

Hand, Foot and Mouth Disease (Phase 2)

Herpangina (Phase 2)

Mouth Diseases (Phase 2)

Oral Ulcer (Phase 2)

Pain, Postoperative (Phase 4)

Stress Disorders, Post-Traumatic (Phase 2)

Stress Disorders, Traumatic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 33
  • # of Trial APIs: 33